Luke Sergott
Stock Analyst at Barclays
(2.33)
# 2,664
Out of 5,054 analysts
349
Total ratings
44.06%
Success rate
-2.59%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Maintains: Overweight | $1,350 → $1,600 | $1,445.06 | +10.72% | 3 | Nov 10, 2025 | |
| NTRA Natera | Maintains: Overweight | $210 → $230 | $206.72 | +11.26% | 5 | Nov 7, 2025 | |
| CERT Certara | Maintains: Overweight | $16 → $14 | $8.58 | +63.17% | 19 | Nov 7, 2025 | |
| TXG 10x Genomics | Maintains: Overweight | $15 → $17 | $16.59 | +2.47% | 14 | Nov 7, 2025 | |
| FTRE Fortrea Holdings | Maintains: Underweight | $8 → $10 | $11.79 | -15.18% | 13 | Nov 6, 2025 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $195 → $210 | $173.50 | +21.04% | 10 | Nov 6, 2025 | |
| SHC Sotera Health Company | Maintains: Overweight | $19 → $20 | $16.13 | +23.99% | 23 | Nov 5, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $65 → $77 | $67.50 | +14.07% | 8 | Nov 4, 2025 | |
| BRKR Bruker | Maintains: Overweight | $40 → $45 | $41.73 | +7.84% | 7 | Nov 4, 2025 | |
| ILMN Illumina | Maintains: Underweight | $95 → $100 | $122.60 | -18.43% | 21 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $85 | $97.71 | -13.01% | 5 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $15 → $12 | $11.50 | +4.35% | 27 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $160 → $175 | $153.44 | +14.05% | 3 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $105 | $94.31 | +11.33% | 11 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $275 → $325 | $277.41 | +17.16% | 4 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $425 → $485 | $602.77 | -19.54% | 4 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $190 → $185 | $163.42 | +13.21% | 22 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $585 → $625 | $586.49 | +6.57% | 29 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $225 → $250 | $215.79 | +15.85% | 41 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $125 → $150 | $149.42 | +0.39% | 12 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $185 → $200 | $218.53 | -8.48% | 24 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 → $53 | $44.22 | +19.86% | 2 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $45 → $40 | $31.32 | +27.71% | 18 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $108.16 | -16.79% | 1 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2 → $1.5 | $1.86 | -19.35% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $400 → $350 | $386.14 | -9.36% | 18 | Apr 10, 2025 |
Mettler-Toledo International
Nov 10, 2025
Maintains: Overweight
Price Target: $1,350 → $1,600
Current: $1,445.06
Upside: +10.72%
Natera
Nov 7, 2025
Maintains: Overweight
Price Target: $210 → $230
Current: $206.72
Upside: +11.26%
Certara
Nov 7, 2025
Maintains: Overweight
Price Target: $16 → $14
Current: $8.58
Upside: +63.17%
10x Genomics
Nov 7, 2025
Maintains: Overweight
Price Target: $15 → $17
Current: $16.59
Upside: +2.47%
Fortrea Holdings
Nov 6, 2025
Maintains: Underweight
Price Target: $8 → $10
Current: $11.79
Upside: -15.18%
Charles River Laboratories International
Nov 6, 2025
Maintains: Overweight
Price Target: $195 → $210
Current: $173.50
Upside: +21.04%
Sotera Health Company
Nov 5, 2025
Maintains: Overweight
Price Target: $19 → $20
Current: $16.13
Upside: +23.99%
Exact Sciences
Nov 4, 2025
Maintains: Overweight
Price Target: $65 → $77
Current: $67.50
Upside: +14.07%
Bruker
Nov 4, 2025
Maintains: Overweight
Price Target: $40 → $45
Current: $41.73
Upside: +7.84%
Illumina
Oct 31, 2025
Maintains: Underweight
Price Target: $95 → $100
Current: $122.60
Upside: -18.43%
Oct 30, 2025
Maintains: Overweight
Price Target: $70 → $85
Current: $97.71
Upside: -13.01%
Oct 30, 2025
Downgrades: Equal-Weight
Price Target: $15 → $12
Current: $11.50
Upside: +4.35%
Oct 29, 2025
Maintains: Overweight
Price Target: $160 → $175
Current: $153.44
Upside: +14.05%
Oct 28, 2025
Maintains: Overweight
Price Target: $100 → $105
Current: $94.31
Upside: +11.33%
Oct 27, 2025
Maintains: Equal-Weight
Price Target: $275 → $325
Current: $277.41
Upside: +17.16%
Oct 24, 2025
Maintains: Underweight
Price Target: $425 → $485
Current: $602.77
Upside: -19.54%
Oct 24, 2025
Maintains: Equal-Weight
Price Target: $190 → $185
Current: $163.42
Upside: +13.21%
Oct 23, 2025
Maintains: Overweight
Price Target: $585 → $625
Current: $586.49
Upside: +6.57%
Oct 22, 2025
Maintains: Overweight
Price Target: $225 → $250
Current: $215.79
Upside: +15.85%
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $125 → $150
Current: $149.42
Upside: +0.39%
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $185 → $200
Current: $218.53
Upside: -8.48%
Oct 2, 2025
Maintains: Overweight
Price Target: $55 → $53
Current: $44.22
Upside: +19.86%
Oct 2, 2025
Maintains: Overweight
Price Target: $45 → $40
Current: $31.32
Upside: +27.71%
Aug 1, 2025
Initiates: Overweight
Price Target: $90
Current: $108.16
Upside: -16.79%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $2 → $1.5
Current: $1.86
Upside: -19.35%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $400 → $350
Current: $386.14
Upside: -9.36%